Glioma cells had been transfected with 100nM antagomir-19a (or adverse control). part, through up-regulating LRIG1. Keywords: miRNA-19a, LRIG1, glioma, proliferation == Launch == Malignant gliomas are the most common and incurable brain tumors [1]. Despite the advance in surgery, ionizing radiation and chemotherapy, the prognosis of patients is still poor [2]. Extensive understanding of the molecular mechanisms underlying gliomagenesis is important to develop specific therapeutic strategies. microRNAs (miRNAs) are a class of small non-coding RNAs which negatively regulate gene expression at the post-transcriptional level by directly binding to the 3untranslated region (3UTR) of target mRNAs [3, 4]. Accumulating Azelaic acid evidence suggests that deregulated miRNAs play crucial roles in the initiation and progression of gliomas [5, 6], such as miRNA-21 [7], miRNA-221/222 [8], ainsi que al. Previous miRNA profiling data demonstrated that the manifestation of miRNA-19a was increased during the progression of glioma [6]. However , its biological functions in glioma remain to become elucidated. LRIG1 (leucine-rich repeats and immunoglobulin-like domains1) is actually a pan-negative regulator of membrane-bound receptor tyrosine kinases (RTKs) [9-13]. Previous studies showed that Azelaic acid LRIG1 was down-regulated in gliomas, whereas ectopic over-expression of LRIG1 was competent of inhibiting glioma cell growth. Accordingly, LRIG1 was proposed to become a tumor suppressor in glioma [13, 14]. Although decreased LRIG1 levels were found to become correlated with malignancy of glioma [14, 15], we failed to establish an association between mRNA levels of LRIG1 and the World Wellness Organization (WHO) grades of glioma in our preliminary research (unpublished results). So , we hypothesized the decreased levels of LRIG1 proteins might feature to a variety of post-transcriptional regulatory mechanisms. In present research, we discovered that miRNA-19a was up-regulated in gliomas. Down-regulation of miRNA-19a decelerated glioma cell growth and increased the expression of LRIG1. Moreover, we identified that LRIG1 was a functional focus on of miRNA-19a in glioma. == Components and methods == == Tissue specimens == This study was approved by the Ethics Committee of Wuhan University. Knowledgeable consent was obtained from each patient. A total of 29 glioma examples were collected at the Division of Neurosurgery, Renmin Hospital of Wuhan Azelaic acid University. According to the WHO groups, 14 grade I-II tumors, 7 grade III tumors, and eight grade IV tumors were included in our study. Five normal brain tissues were obtained from individuals who underwent internal decompression surgery to get severe traumatic brain damage. Fresh examples were immediately frozen in liquid nitrogen for following RNA extraction. == Cell culture == Human U251, U87, A172, and U118 glioma cell lines were purchased coming from Shanghai Institutes for Biological Sciences, Chinese language Academy of Sciences. These cell lines were cultured in Dulbeccos modified Eagles medium (Hyclone, USA) supplemented with 10% fetal bovine serum (Gibco, USA), 100 U/ml penicillin, and 100 g/ml streptomycin. The cells were incubated at 37C in a 5% CO2atmosphere. == Oligonucleotides transfection == Synthetic cholesterol-conjugated miRNA-19a inhibitor (antagomir-19a: 5-UCAGUUUUGCAUAGAUUUGCACA-3) and negative control (antagomir-NC: 5-CAGUACUUUUGUGUAGUACAA-3) were purchased from Genepharma (Shanghai, China). The small interfering RNA concentrating on LRIG1 (siLRIG1: 5-ACTCTCTGAGATTGACCCT-3) as well as negative control oligonucleotides (siNC: 5-ACTACCGTTGTTATAGGTG-3) were synthesized by RiboBio (GuangZhou, China). The previously reported sequences were used [16]. Transfection of oligonucleotides was performed using HiPerFect Transfection Reagent (Qiagen, Germany) according to the producers instructions. The oligonucleotides were used at a final focus of 100 nM. == RNA extraction and real-time RT-PCR == Total RNAs were extracted using TRIzol reagent (Invitrogen, Carlsbad, CA). The expression of mature miRNA-19a was based on quantitative real-time RT-PCR (qRT-PCR) using the SYBR PrimeScript miRNA RT-PCR Package (TaKaRa, Ohtsu, Japan) according to the manufacturers protocol. Its manifestation was normalized to U6 small nuclear RNA. The quantitative LRIG1 detection was performed because described previously [16]. GAPDH was used as an internal control. Their particular relative manifestation levels were measured in triplicate on a Prism 7500 Real-Time PCR monitor (Applied Biosystems). Almost all primers were listed inTable Rabbit Polyclonal to OR10A7 1 . == Table 1 . == QPCR primer sequences == Traditional western blot == Western blot was performed as referred to previously [16]. The subsequent primary antibodies were used: anti-LRIG1 antibody (1: 1, 000; Cell Signaling Technology, USA) and anti-GAPDH antibody (1: 2, 000; Santa Cruz Biotechnology,.